Mentavi Chief Medical Officer Barry K. Herman, MD, MMM, presented a poster summarizing Mentavi's recently published study in ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The market size of CGT products is expected to continue to rise by 2031 and reach $63 billion. CGTs have yielded commercial gains for several pharma companies. For example, some of the top-selling CGT ...

As drug candidates discovered via AI move into later-stage clinical trials, the technology seems to be doing as promised: ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

New York, New York--(Newsfile Corp. - January 7, 2026) - Frost & Sullivan has released a white paper titled, "How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with ...

AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to ...

With life sciences organizations moving from experimentation to implementation, AI is becoming a core enabler of innovation ...

To modernize data and infrastructure, HLC recommends expanding transparency standards and mitigating bias. It points to the transparency and disclosure requirements set out in HTI-1 and suggests ...

President Donald Trump took the stage at the World Economic Forum, eager to tell a familiar story: how his trademark threats ...

Cell and gene therapies present promising opportunities, especially in oncology, blood disorders, and neurology. Investors prioritize scalable platforms and clear regulatory paths. Focus has shifted ...